Chi-YuanHsuMDMSc

PubMed

• 65 citations
  Biological Variability of Estimated GFR and Albuminuria in CKD
  Sushrut S. Waikar, Casey M. Rebholz, Zihe Zheng, Shelley Hurwitz, Chi-yuan Hsu
  American Journal of Kidney Diseases. 2018-10-01
• 874 citations
  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
  Tamara Isakova, Patricia Wahl, Gabriela Vargas, Orlando M. Gutiérrez, Julia J. Scialla
  Kidney International. 2011-06-02
• 8544 citations
  CHRONIC KIDNEY DISEASE AND THE RISKS OF DEATH, CARDIOVASCULAR EVENTS, AND HOSPITALIZATION
  Alan S. Go, Glenn M. Chertow, Dongjie Fan, Charles E. McCulloch, Chi-yuan Hsu
  The New England Journal of Medicine. 2004-09-23

Journal Articles

• Implication of Trends in Timing of Dialysis Initiation for Incidence of End-Stage Kidney Disease  
  Chi-Yuan Hsu, Leonid N Pravoverov, Alan S Go, JAMA Internal Medicine
• Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial  
  Daniel E Weiner, Meyeon Park, Alin A Joseph, Nitender Goyal, Chi-Yuan Hsu, Clifton E Kew, Todd E Pesavento, Andrew S Levey, American Journal of Kidney Diseases
• Biological Variability of Estimated GFR and Albuminuria in CKD  
  Sushrut S Waikar, Chi-Yuan Hsu, Harold I Feldman, Kathleen D Liu, Joseph V Bonventre, Lesley A Inker, American Journal of Kidney Diseases
• Serum fibroblast growth factor-23 is associated with incident kidney disease  
  Rebholz CM, Grams ME, Coresh J, Selvin E, Inker LA, Levey AS, Kimmel PL, Vasan RS, Eckfeldt JH, Feldman HI, Hsu CY, Lutsey PL, J Am Soc Nephrol, 1/1/2015
• Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in chronic kidney disease: results from the CRIC Study  
  Liu KD, Yang W, Go AS, Anderson AH, Feldman HI, Fischer MJ, He J, Kallem RR, Kusek JW, Master SR, Miller ER 3rd, Rosas SE, Steigerwalt S, Tao K, Weir MR, Hsu CY, Am J Kidney Dis, 1/1/2015
• Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis  
  Bansal N, McCulloch CE, Rahman M, Kusek JW, Anderson AH, Xie D, Townsend RR, Lora CM, Wright J, Go AS, Ojo A, Alper A, Lustigova E, Cuevas M, Kallem K, Hsu CY, Hypertension, 1/1/2015
• Association of urinary KIM-1, L-FABP, NAG, and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus  
  Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD, Diabetologia, 1/1/2015
• Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease  
  Ku E, Glidden DV, Johansen KL, Sarnak M, Tighiouart H, Grimes B, Hsu CY, Kidney Int, 1/1/2015
• State level variations in nephrology workforce and timing and incidence of dialysis in the United States among children and adults: a retrospective cohort study  
  Ku E, Johansen KL, Portale AA, Grimes B, Hsu CY, BMC Nephrology, 1/1/2015
• Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes  
  Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG, Am J Kidney Dis, 1/1/2015
• Association of body mass index with patient-centered outcomes in children with ESRD  
  Ku E, Glidden DV, Hsu CY, Portale A, Grimes B, Johansen KL, J Am Soc Nephrol, 1/1/2015
• Increasing Incidence of acute kidney injury: also a problem in pregnancy?  
  Lunn MR, Obedin-Maliver J, Hsu CY, Am J Kidney Dis, 1/1/2015
• When change is not a good thing  
  Liu KD, Hsu CY, Clin Chem, 1/1/2015
• Urine stability studies for novel biomarkers of acute kidney injury  
  Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park P, Hsu CY, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD, Am J Kidney Dis, 1/1/2014
• Association of kidney disease outcomes with risk factors for chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study  
  Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI, Am J Kidney Dis, 1/1/2014
• Cardiovascular events after acute kidney injury: a new dimension  
  Hsu CY, Liu KD, J Am Soc Nephrol, 1/1/2014
• Intersection of cardiovascular disease and kidney disease: atrial fibrillation  
  Bansal N, Hsu CY, Go AS, Curr Opin Nephrol Hypertens, 1/1/2014
• Temporal changes in incidence of dialysis-requiring acute kidney injury  
  Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY, J Am Soc Nephrol, 1/1/2013
• A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC Study  
  Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, Go AS, Hamm LL, Kusek JW, Ojo AO, Rahman M, Tao K, Wright JT, Xie D, Hsu CY, Clin J Am Soc Nephrology, 1/1/2013
• Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease  
  Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY, Kidney Int, 1/1/2013
• Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease  
  Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS, Circulation, 1/1/2013
• Estimating prevalence of CKD stages 3-5 using health system data  
  Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R, Am J Kidney Dis, 1/1/2013
• Healthy behaviors, risk factor control and awareness of chronic kidney disease  
  Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, Gutiérrez OM, Safford M, Powe NR, McClellan WM, Am J Nephrol, 1/1/2013
• Urine biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have different patterns in heart failure exacerbation  
  Park M, Vittinghoff E, Liu KD, Shlipak M, Hsu CY, Biomark Insights, 1/1/2013
• Regional variation in the incidence of dialysis-requiring acute kidney injury in the US  
  Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY, Clin J Am Soc Nephrology, 1/1/2013
• Join now to see all

Books/Book Chapters

• Primer on Kidney Disease 
  Chapter: Clinical evaluation of kidney function 
  Page 20.0 - 25.0Hsu CYEditors: Greenberg A.Elsevier Saunders, PhiladelphiaEdition 4th,2005

Lectures

• Diabetes and Advanced CKD: Diabetologists and Nephrologists on the Frontline--ASN/ADA Joint Session 
  Philadelphia, PA - 1/1/2014
• Toward Building Better Biomarkers Statistical Methodology 
  Bethesda, MD - 1/1/2014
• Novel Biomarkers of Kidney Disease 
  Atlanta, GA - 1/1/2013
• CVD in CKD: What’s in the toolbox…and what to do with results 
  Atlanta, GA - 1/1/2013
• Outcomes after AKI 
  Atlanta, GA - 1/1/2013
• Advances in geriatric nephrology 
  San Diego, CA - 1/1/2012
• Critical care nephrology: 2011 update 
  Philadelphia, PA - 1/1/2011
• Critical care nephrology: 2010 update 
  Denver, CO - 1/1/2010
• Critical care nephrology: 2009 update 
  San Diego, CA - 1/1/2009
• Critically approaching the literature: applying the principles of epidemiology and biostatistics 
  Multiple locations, 2005, 2006, 2007, 2008 - 1/1/2008
• Workshop on Assessment of Kidney Function and Damage 
  Bethesda, MD - 1/1/2008
• Debates in Renal Disease 
  Philadelphia, PA - 1/1/2008
• Join now to see all

Other

• Biomarkers in chronic kidney disease 
  Bansal N, Hsu CY, ASN Kidney News
  1/1/2014
• Mini-Sentinel Validation of Acute Kidney Injury Cases 
  Patel UD, Hardy NC, Smith DH, Gurwitz JH, Hsu CY, Parikh CR, Brunelli SM, Baker M, Forrow S, Comins C, Boudreau DM, Liu C, Pawloski PA, Selvam N, Selvan MS, Stratton S...
  www.minisentinel.org/methods/outcome_validation
  1/1/2013